- Idex has narrowed its full-year organic sales forecast to a 1% increase, down from the previous estimate of 1% to 3% growth.
- For the third quarter, the company projects organic sales growth between 2% and 3%.
- In the second quarter, Idex’s adjusted earnings per share (EPS) reached $2.07, surpassing the expected $1.99.
- Net sales for the quarter stood at $865.4 million, exceeding the forecast of $858.7 million.
- Fluid & Metering Technologies reported net sales of $310.9 million, slightly below the estimated $316.3 million.
- Health & Science Technologies achieved net sales of $365.3 million.
- Fire & Safety/Diversified Products reported net sales of $191.5 million, above the anticipated $190.1 million.
- Idex’s adjusted EBITDA was $237.2 million, higher than the expected $230.9 million.
- The Fluid & Metering Technologies segment recorded an adjusted EBITDA of $108.7 million.
- Health & Science Technologies had an adjusted EBITDA of $95.0 million.
- Fire & Safety/Diversified Products reported an adjusted EBITDA of $56.4 million, surpassing the estimated $50.7 million.
- The adjusted gross margin was 45.3%, slightly higher than the forecasted 45%.
- Investment analysts’ ratings on Idex include 8 “buys” and 7 “holds,” with no “sells.”
Idex Corp on Smartkarma
On Smartkarma, independent analysts from Baptista Research are providing insightful coverage on Idex Corp, shedding light on the company’s future growth potential and strategic investments. In a bullish sentiment, Baptista Research highlighted Idex Corp‘s strong performance in the first quarter of 2025, surpassing expectations in revenue, profitability, and adjusted earnings per share. The company’s effective operational management, despite uncertainties like newly introduced tariffs, sets a positive tone for Idex Corp‘s trajectory.
Furthermore, Baptista Research delves into Idex Corp‘s strategic growth investments and key drivers, emphasizing the company’s solid financial showing in the fourth quarter and full year of 2024. The successful acquisition and integration of Mott is singled out as a significant accomplishment, bolstering Idex Corp‘s capabilities in the filtration sector and positioning the company for growth in energy transition markets. The seamless performance of Mott post-integration exceeded expectations and immediately contributed to Idex Corp‘s bottom line, underscoring the company’s strategic prowess in navigating complex market landscapes.
A look at Idex Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Idex Corp seems to have a balanced outlook for the long term. With a solid score of 3 in Value, Dividend, Growth, and Resilience, the company demonstrates stability across key factors. In addition, its Momentum score of 4 indicates a slightly stronger upward trend in the near future. This suggests that while Idex Corp is not leading in any single aspect, it maintains a steady performance across multiple areas, which could bode well for its future prospects.
IDEX Corporation, known for its diverse range of pump products, dispensing equipment, and engineered solutions, operates both in the domestic United States market and internationally. The company’s product portfolio includes industrial pumps, lubrication systems, banding and clamping devices, and rescue tools. With a balanced Smart Score profile, Idex Corp appears to be positioned to navigate various market conditions while continuing to serve its customers with innovative solutions.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
